好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2007 Annual Meeting | Women's Issues in Cerebrovascular Diseases

Sunday 04/29/07
09:00 AM - 12:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
AM Half-Day Course
Cathy A. Sila, MD, FAAN
Women's Issues
Participants should be familiar with the diagnosis, prevention, and treatment of a variety of cerebrovascular disorders in women with a focus on those factors that render women different from their male counterparts.
No CME available
Medical Knowledge, Practice-based Learning and Improvement
Advanced
Practitioner, Fellow, Academician, Resident, Nurse
Event Timeline
09:00 AM - 09:45 AM The Importance of Gender in Cerebrovascular Disease
Irene L. Katzan, MD
09:45 AM - 10:30 AM The Borderland of Migraine and Stroke
Gretchen E. Tietjen, MD
10:30 AM - 10:45 AM Break
10:45 AM - 11:30 AM Extending the Differential Diagnosis: Unusual Causes of Stroke
Cathy A. Sila, MD, FAAN
11:30 AM - 12:15 PM Hormones and Hypercoagulable States
Cheryl Bushnell, MD, MHS
12:15 PM - 12:45 PM Ask the Experts: Difficult Cases
Faculty Disclosures
Cathy A. Sila, MD, FAAN Dr. Sila has nothing to disclose.
Cheryl Bushnell, MD, MHS The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Irene L. Katzan, MD Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
Gretchen E. Tietjen, MD An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.